Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience, Named to PharmaVOICE 100

PharmaVOICE100_Version4-2

BOSTON AND NEW YORK – AUGUST 03, 2020

LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced that Donna L. LaVoie, President, CEO and Founder of LHS, has been named to the PharmaVOICE 100 Most Inspiring People in the life-sciences industry.

Since 2005, the PharmaVOICE 100 has honored more than 1,500 industry executives for their contributions to the life sciences. It remains the only awards program that recognizes achievement across all sectors of the life science industry. This year, Donna joins a list of 99 other inspirational, accomplished leaders who are continuing to drive health and science innovation.

As a proven leader in strategic communications for pharmaceutical, biotechnology, healthcare, medical device and medical technology companies, Donna was named to the PharmaVOICE 100 for her influence as a corporate leader, passion and conviction for the industry and her ability to think outside the box and develop and implement breakthrough, integrated communications strategies. In addition, the recognition highlights how she has inspired and motivated those around her as a mentor and through her many positive contributions to the industry.

To date, LHS has served more than 375 commercial and pre-commercial clients, both domestic and global. After founding LHS in 2001, Donna has steadily grown the agency by overseeing key account strategies, forming strategic alliances with industry collaborators, building a strong senior management team capable of mentoring the next generation of life science leaders and expanding the agency’s presence in Boston and New York City. Donna is the architect behind LHS’ core methodologies, including LHS Immersion® — a message development and positioning platform for established and emerging companies — and the LHS Fifteen-Slide Presentation®.

“It is a great honor to be included this year in the PharmaVOICE 100,” said Donna L. LaVoie. “I continue to be inspired each day by the dedication of my team and the breakthrough work our clients do to bring advances in health and improve patient lives. We are operating during an extremely difficult time and rising to meet the challenges presented to us is more important than ever. We must keep moving to drive innovation.”

Donna and the other 2020 honorees will be celebrated during 24-hours of digital programming on Thursday, September 10 that will include interactive panels, networking opportunities, video interviews and more.

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, relationship building and marketing. The firm provides strategic consulting, public relations and investor relations to build recognition and increase sales and value for health science innovations and has two trademarked methodologies for its strategic communications’ advisory services. The agency has received over 50 awards in recognition of the work done by its strategic thinkers for health and science industry-leading clients. LHS was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies, as well as ranked on the O’Dwyer’s list of 2020 Healthcare Public Relations Firms and Boston Business Journal’s Largest PR Firms in Massachusetts.

Agency and Media Contact:
Katie Gallagher
Account Director, PR and Marketing
617-792-3937
kgallagher@lavoiehealthscience.com

Share This Post